The ALERTS Clinical Study

ConsultationThe ALERTS Clinical study was designed to test the efficacy of the AngelMed Guardian System as an adjunct to symptoms for more accurate detection of ACS events, including silent events, while reducing false positives . The trial was concluded in 2017.

To find out more about the ALERTS clinical study, please visit the Clinical Trials website of the US National Institutes of Health. Also, check the Patient Stories section to learn about some of the people who participated in the ALERTS clinical study.

Please note that the ALERTS study was completed in 2017 and can therefore no longer accept new participants.

ALERTS Study Site Locations

Click a state for a list of ALERTS locations.